Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Glutamate receptor 2 precursor | 0.0037 | 0.013 | 1 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0094 | 0.1523 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0445 | 1 | 1 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0131 | 0.2414 | 0.2325 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.0196 | 0.0082 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0369 | 0.8173 | 1 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus multilocularis | glutamate receptor ionotropic kainate | 0.0037 | 0.013 | 0.0014 |
Echinococcus granulosus | Ribosomal protein S1 RNA binding domain | 0.0037 | 0.013 | 0.0014 |
Echinococcus granulosus | glutamate receptor ionotropic kainate 3 | 0.0037 | 0.013 | 0.0014 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus multilocularis | Ribosomal protein S1, RNA binding domain | 0.0037 | 0.013 | 0.0014 |
Echinococcus multilocularis | glutamate receptor subunit protein glur | 0.0037 | 0.013 | 0.0014 |
Brugia malayi | Glutamate receptor 1 precursor | 0.0037 | 0.013 | 1 |
Chlamydia trachomatis | glutamine binding protein | 0.0094 | 0.1523 | 0.5 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0037 | 0.013 | 0.0014 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0094 | 0.1523 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0333 | 0.7282 | 0.725 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0094 | 0.1523 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0333 | 0.7282 | 0.725 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0314 | 0.6825 | 0.6788 |
Echinococcus granulosus | glutamate receptor 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0056 | 0.0587 | 0.0476 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0094 | 0.1523 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.0196 | 0.0082 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0058 | 0.5 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0058 | 0.5 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0037 | 0.013 | 0.0014 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0036 | 0.0116 | 0.8904 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0314 | 0.6825 | 0.6788 |
Echinococcus multilocularis | NMDA receptor | 0.0037 | 0.013 | 0.0014 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.0037 | 0.013 | 1 |
Echinococcus granulosus | glutamate receptor ionotropic kainate | 0.0037 | 0.013 | 0.0014 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0056 | 0.0587 | 0.0476 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.0037 | 0.013 | 1 |
Echinococcus granulosus | glutamate receptor subunit protein glur | 0.0037 | 0.013 | 0.0014 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0094 | 0.1523 | 0.5 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0037 | 0.013 | 0.0014 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
T1/2 (ADMET) | = 70 min | Half-life of the compound was determined using mouse brain homogenate | ChEMBL. | 12643900 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.